Fundraising FoxSV Life Sciences — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
Ophthotechophthotech.comOct 2018 · $30M
BiotechNew York, US
David Guyer(Executive Officer, Director)Glenn Sblendorio(Executive Officer, Director)Mike AtiehinDavid Redlick(Director)Keith Westby(Executive Officer)David Carroll(Executive Officer)
Co-investorsSofinnova VenturesSV Health InvestorsClarus Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.